Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry

Show other versions (1)

Bibliographic Details
Main Authors:	Neubauer, S, Kolm, P, Ho, C, Desai, M, Dolman, SF, Appelbaum, E, Desvigne-Nickens, PM, Dimarco, JP, Friedrich, MG, Geller, N, Jerosch-Herold, M, Kim, D-Y, Maron, MS, Schulz-Menger, J, Piechnik, SK, Zhang, C, Weintraub, WS, Kramer, CM, Watkins, H
Format:	Conference item
Language:	English
Published:	American Heart Association 2019

Similar Items

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
by: Neubauer, S, et al.
Published: (2019)

Predictors of clinically significant atrial fibrillation in the NHLBI hypertrophic cardiomyopathy registry (HCMR)
by: Kramer, C, et al.
Published: (2020)

Correlates of myocardial fibrosis in hypertrophic cardiomyopathy
by: Kramer, CM, et al.
Published: (2018)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

Global extracellular volume (ECVglobal) in HCM - the "next generation" test for risk in hypertrophic cardiomyopathy?
by: Sado Daniel, et al.
Published: (2013-01-01)

Septal Ablation in Obstructive Hypertrophic Cardiomyopathy (oHCM)
by: Dirceu Rodrigues Almeida
Published: (2019-04-01)

Molecular Diagnosis of Hypertrophic Cardiomyopathy (HCM): In the Heart of Cardiac Disease
by: Marilena Melas, et al.
Published: (2022-12-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

NHLBI support of Systems Biology
by: Pankaj eQasba, et al.
Published: (2013-11-01)

Venous dysfunction in obstructive hypertrophic cardiomyopathies: Results from the “HCM-Vein” pilot study
by: Patricia Réant, et al.
Published: (2023-04-01)

Complement system specifically C5a receptor, inflammation and hypertrophic cardiomyopathy (HCM) in cats
by: Khor, Kuan Hua
Published: (2015)

Novel mutations in cardiac MYPBC3 cause early onset malignant hypertrophic cardiomyopathy (HCM)
by: Carballo, S, et al.
Published: (2005)

Myocardial T1 mapping and extracellular volume quantification: an overview of technical and biological confounders
by: Piechnik, S, et al.
Published: (2017)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: New insights from multiparametric MRI
by: Petersen, S, et al.
Published: (2007)

Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program.
by: Carol A Giffen, et al.
Published: (2017-01-01)

Clinical Application of the HCM-AF Risk Score in the Prediction of Clinical Outcomes of Polish Patients with Hypertrophic Cardiomyopathy
by: Maria Stec, et al.
Published: (2023-07-01)

METABOLIC ALTERATION IN HYPERTROPHIC CARDIOMYOPATHY (METAL-HCM STUDY): RANDOMISED DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OF PERHEXILINE THERAPY IN PATIENT WITH HYPERTROPHIC CARDIOMYOPATHY
by: Abozguia, K, et al.
Published: (2010)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
by: Raman, B, et al.
Published: (2017)

Delineating the role of adenosine monophosphate (AMP)-activated protein kinase (AMP) gamma 2 subunit in hypertrophic cardiomyopathy (HCM)
by: Grignani, R, et al.
Published: (2005)

ATTR Gene Variants in HCM
by: Anthony J. Kanelidis, MD, et al.
Published: (2024-03-01)

Reply: CMR assessment of myocyte disarray in HCM: matching another piece in the puzzle
by: Ariga, R, et al.
Published: (2019)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
by: Karamitsos, T, et al.
Published: (2013)

Flow inefficiencies in non-obstructive HCM revealed by kinetic energy and hemodynamic forces on 4D-flow CMR
by: Pola, K, et al.
Published: (2024)

Inhibition of miR-199a-3p in a murine hypertrophic cardiomyopathy (HCM) model attenuates fibrotic remodeling
by: Irina Zalivina, et al.
Published: (2023-12-01)

Mouse HCM Model Expression E99K ACTC Mutation Reproduces the Clinical HCM Phenotype
by: Song, W, et al.
Published: (2009)

Serial quantification of myocardial infarction tissue heterogeneity during infarct healing by cardiac MRI provides strong characterization of left ventricular remodeling (the NHLBI PROSPECT-CMR Study)
by: Antman Elliott, et al.
Published: (2011-02-01)

Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
by: Petersen, SE, et al.
Published: (2007)

Left and right ventricular tissue velocities are reduced in hypertrophic cardiomyopathy but not in athlete's heart
by: Petersen, SE, et al.
Published: (2008)

HCM2010 : highway capacity manual /
by: National Research Council (U.S.). Transportation Research Board
Published: (2010)

Sarcomeric versus Non-Sarcomeric HCM
by: Felice Borrelli, et al.
Published: (2023-06-01)

Prolonged mHealth-Based Arrhythmia Monitoring in Patients With Hypertrophic Cardiomyopathy (HCM-PATCH): Protocol for a Single-Center Cohort Study
by: Sophia Schulze Lammers, et al.
Published: (2023-12-01)

2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance
by: Manning Warren J, et al.
Published: (2008-10-01)

Risk stratification in hypertrophic cardiomyopathy based on QRS and T wave morphological biomarkers identifies three phenotypic subgroups
by: Lyon, A, et al.
Published: (2016)

2055 Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy
by: Manning Warren J, et al.
Published: (2008-10-01)

Reduced hyperemic myocardial blood flow in hypertrophic cardionnyopathy: New insights from multi-parametric magnetic resonance imaging
by: Petersen, SE, et al.
Published: (2006)

NHLBI Step-by-Step Approach to Adapting Cardiovascular Training and Education Curricula for Diverse Audiences
by: Robinson Fulwood, PhD, MSPH, et al.
Published: (2008-04-01)

Likelihood of Null Effects of Large NHLBI Clinical Trials Has Increased over Time.
by: Robert M Kaplan, et al.
Published: (2015-01-01)

The West Philadelphia asthma care implementation study (NHLBI# U01HL138687)
by: Tyra Bryant-Stephens, MD, et al.
Published: (2021-12-01)

Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation
by: Sharaf Barry L, et al.
Published: (2008-03-01)

Whole-genome association analyses of sleep-disordered breathing phenotypes in the NHLBI TOPMed program
by: Brian E. Cade, et al.
Published: (2021-08-01)